RITUXIMAB

158103 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking RITUXIMAB:

# Side effect Count
0 DRUG INEFFECTIVE 28166
1 OFF LABEL USE 25159
2 RHEUMATOID ARTHRITIS 16101
3 PAIN 13376
4 FATIGUE 12966
5 ARTHRALGIA 10137
6 DRUG INTOLERANCE 9793
7 RASH 9658
8 INFUSION RELATED REACTION 9123
9 JOINT SWELLING 8719
See all common reactions for RITUXIMAB

RITUXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3512 0.8388
1 SWOLLEN JOINT COUNT INCREASED 1039 0.8149
2 PEMPHIGUS 6533 0.7778
3 RHEUMATIC FEVER 1233 0.7266
4 RHEUMATOID FACTOR POSITIVE 2583 0.6960
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 410 0.6743
6 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 928 0.6549
7 DUODENAL ULCER PERFORATION 2497 0.6398
8 GRANULOMA SKIN 450 0.6207
9 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 318 0.6104
See all enriched reactions for RITUXIMAB